EUVIMEDEUVIMED entdecken
Randomisierte kontrollierte StudieOpen Access

Opioids diminish the placebo antidepressant response: Observational post hoc findings from a randomized controlled ketamine trial

Theresa R Lii, Josephine R Flohr, Robin L Okada, Lisa J Cianfichi, Laura M Hack, Alan F Schatzberg, Boris D Heifets

Journal of Affective Disorders · 2025

DOI: 10.1016/j.jad.2025.04.008 ↗

Kurz gefasst

Randomisierte kontrollierte Studie in der Zeitschrift Journal of Affective Disorders, 2025. Verfasst von Theresa R Lii und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Anesthesiology, Perioperative and Pain Medicine, Stanford University School of Medicine, Stanford, CA, USA. Hauptthemen laut MEDLINE: Ketamine, Analgesics, Opioid, Placebo Effect, Antidepressive Agents. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 21 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIDA NIH HHS, NIGMS NIH HHS, NIH National Institute of General Medical Sciences.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND: The endogenous opioid system is thought to play a role in the placebo antidepressant response. A recent trial comparing the rapid antidepressant effects of ketamine versus placebo in surgical patients, some of whom were on chronic opioid therapy, revealed a substantial placebo effect. This finding provided an opportunity to test the hypothesis that opioid agonist exposure interacts with placebo antidepressant responses. METHODS: This post hoc analysis utilized data from a previously reported randomized, anesthesia-blinded, placebo-controlled trial of intravenous ketamine in depressed patients undergoing routine surgery. Mixed-effects models were used to determine whether baseline opioid use influenced antidepressant responses to the trial interventions, as measured by the Montgomery-Åsberg Depression Rating Scale (MADRS) over 1 to 14 days post-treatment. RESULTS: The analysis showed that baseline opioid use significantly reduced post-treatment depression severity in patients who received placebo, but not in those who received ketamine. This reduction was independent of baseline depression severity, baseline pain intensity, and ethnicity. Additionally, there was negligible correlation between postoperative pain intensity and depression severity. LIMITATIONS: This post hoc analysis was conducted on a small sample, and the findings need to be confirmed by prospective controlled studies. CONCLUSIONS: Opioid use at baseline attenuated the placebo antidepressant response independently of pain in depressed patients who received the study treatment under general anesthesia for routine surgery. The antidepressant response was preserved in opioid users who received intravenous ketamine.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

KetamineAnalgesics, OpioidPlacebo EffectAntidepressive AgentsMajor Depressive DisorderHumansFemaleMaleAdultMiddle AgedDouble-Blind MethodPostoperative PainTreatment Outcome

Stichwörter der Autor:innen

AntidepressantDepressionKetamineOpioidsPlacebo

Substanzen

KetamineAnalgesics, OpioidAntidepressive Agents

Autor:innen und Institutionen

  • Department of Anesthesiology, Perioperative and Pain Medicine, Stanford University School of Medicine, Stanford, CA, USA.
  • Department of Radiology, Stanford University School of Medicine, Stanford, CA, USA.
  • Department of Psychiatry and Behavioral Sciences, Stanford University School of Medicine, Stanford, CA, USA; Sierra Pacific Mental Illness Research, Education, and Clinical Center, Veterans Affairs Palo Alto Health Care…
  • Department of Psychiatry and Behavioral Sciences, Stanford University School of Medicine, Stanford, CA, USA.
  • Department of Anesthesiology, Perioperative and Pain Medicine, Stanford University School of Medicine, Stanford, CA, USA; Department of Psychiatry and Behavioral Sciences, Stanford University School of Medicine, Stanfor…

Förderung

  • NIDA NIH HHS
  • NIGMS NIH HHS
  • NIH National Institute of General Medical Sciences
  • Society for Neuroscience in Anesthesiology and Critical Care
  • National Institute on Drug Abuse

Zitieren

APA

Lii, T. R., Flohr, J. R., Okada, R. L., Cianfichi, L. J., Hack, L. M., Schatzberg, A. F., & Heifets, B. D. (2025). Opioids diminish the placebo antidepressant response: Observational post hoc findings from a randomized controlled ketamine trial. Journal of Affective Disorders. https://doi.org/10.1016/j.jad.2025.04.008

Vancouver

Lii TR, Flohr JR, Okada RL, Cianfichi LJ, Hack LM, Schatzberg AF, et al. Opioids diminish the placebo antidepressant response: Observational post hoc findings from a randomized controlled ketamine trial. Journal of Affective Disorders. 2025. doi:10.1016/j.jad.2025.04.008

BibTeX
@article{Lii2025,
  author = {Lii, Theresa R and Flohr, Josephine R and Okada, Robin L and Cianfichi, Lisa J and Hack, Laura M and Schatzberg, Alan F and Heifets, Boris D},
  title = {Opioids diminish the placebo antidepressant response: Observational post hoc findings from a randomized controlled ketamine trial},
  journal = {Journal of Affective Disorders},
  year = {2025},
  doi = {10.1016/j.jad.2025.04.008}
}
Kostenlos starten →